Michael Swartzburg
Plus aucun poste en cours
Provenance du réseau au premier degré de Michael Swartzburg
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 16 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Michael Swartzburg via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Sales & Marketing | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| GILEAD SCIENCES, INC. | Biotechnology | Sales & Marketing | |
| PFIZER, INC. | Pharmaceuticals: Major | Sales & Marketing | |
| BIOGEN INC. | Pharmaceuticals: Major | Sales & Marketing | |
| VIVUS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
| CTI BIOPHARMA CORP. | Pharmaceuticals: Major | Corporate Officer/Principal | |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Goldman Sachs International
 Goldman Sachs International Investment Banks/BrokersFinance Goldman Sachs International (GSI) is the Great Britain-based, wholly-owned brokerage subsidiary of Goldman Sachs Group UK Ltd., ultimately held by The Goldman Sachs Group, Inc. (NYSE: GS) in the US. The firm was founded in 1988 and formerly known as Trushelfco Ltd. Headquartered in London, GSI provides prime brokerage, securities lending, futures services and financing services for a range of clients such as corporations, financial institutions, governments and high-net worth individuals. | Investment Banks/Brokers | Analyst-Equity | |
| HALOZYME THERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| AMBIT BIOSCIENCES CORP | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Nodality, Inc.
 Nodality, Inc. BiotechnologyHealth Technology Nodality, Inc. develops bioinformatics tools to enhance drug development process. Its technology profiles signaling networks in single cells by multiparametric phospho-flow cytometry. The company was founded by Michael C. Needels, Omar D. Perez, Garry P. Nolan and Rodney Weldon Turner in 2003 and is headquartered in San Francisco, CA. | Biotechnology | Sales & Marketing | |
Elicio Therapeutics, Inc. (Old)
 Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
| TURG POIN | Pharmaceuticals: Major | Chief Executive Officer | |
| University of Virginia | College/University | Undergraduate Degree | |
The Boston Consulting Group, Inc.
 The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services The Boston Consulting Group, Inc. engages in the provision of management consulting services. It specializes in automotive and mobility; biopharmaceuticals; consumer products; education; oil and gas; power and utilities; engineered products and infrastructure; financial institutions; and health care payers, providers, and services. It offers big data and advanced analytics; change management; client learning and enablement; and corporate development and financial services. The company was founded by Bruce Doolin Henderson in 1963 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| AROVELLA THERAPEUTICS LIMITED | Pharmaceuticals: Major | Director/Board Member | |
| University of California, Los Angeles | College/University | Undergraduate Degree | |
| CARDIFF ONCOLOGY, INC. | Medical Specialties | Director/Board Member | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree | |
| The University of Chicago | College/University | Masters Business Admin | |
| US Military Academy | College/University | Undergraduate Degree | |
| AVEO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
American Cancer Society, Inc.
 American Cancer Society, Inc. Miscellaneous Commercial ServicesCommercial Services American Cancer Society, Inc. provides information on cancer occurrence, survival, prevention, early detection, and treatment. The non-profit company is based in Kennesaw, GA and has subsidiaries in the United States. The company's SHES department is an intramural research program with world-renowned epidemiologists and health scientists. The company was founded in 1913 by Candy Arrington. Karen E. Knudsen has been the CEO of the company since 2021. | Miscellaneous Commercial Services | Director/Board Member | |
| University of Hamburg | College/University | Doctorate Degree | |
| Pontifícia Universidade Católica de São Paulo | College/University | Doctorate Degree | |
| Moscow Institute of Physics & Technology | College/University | Undergraduate Degree | |
| Université Paris Dauphine-PSL | College/University | Undergraduate Degree | |
| ESSEC Business School | College/University | Masters Business Admin | |
| The United States Army (District of Columbia) | Sovereign | Corporate Officer/Principal | |
| Androclus Therapeutics, Inc. | Chief Executive Officer | ||
| The University of North Carolina at Charlotte | College/University | Doctorate Degree | |
NuMedii, Inc.
 NuMedii, Inc. Miscellaneous Commercial ServicesCommercial Services NuMedii, Inc. discovers and de-risks effective new drugs by translating Life Sciences Big Data into therapies. Its Big Data technology, originally developed at Stanford University, utilizes large amounts of scientific data together with proprietary biological network-based algorithms to discover drug-disease connections and biomarkers that are predictive of efficacy. The firm translates these predictions into novel de-risked drug candidates and partners with pharmaceutical companies for development and commercialization. The company was founded by Gini Deshpande, Joel Dudley and Atul J. Butte in 2008 and is headquartered in Palo Alto, CA. | Miscellaneous Commercial Services | Director/Board Member | |
| ADVERUM BIOTECHNOLOGIES, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| IGNYTA INC | Biotechnology | Corporate Officer/Principal | |
| Tufts University School of Medicine | College/University | Doctorate Degree | |
| University of Pennsylvania Medical Center | College/University | Doctorate Degree | |
Alpine Bioventures, GP, LLC
 Alpine Bioventures, GP, LLC Investment ManagersFinance Alpine Bioventures, GP, LLC (Alpine Bioventures) is a venture capital firm founded by Mitchell H. Gold in 2013. The firm is headquartered in Seattle, Washington. | Investment Managers | Private Equity Investor | |
CTx Operations, Inc.
 CTx Operations, Inc. BiotechnologyHealth Technology CTx Operations, Inc. operates as a pre-clinical stage biotechnology company. It develops novel cellular therapeutics. The company was founded by Saar Gill and Michael Klichinsky in 2017 and is headquartered in Philadelphia, PA. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| IN8BIO, INC. | Biotechnology | Director/Board Member | |
| TSCAN THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| ONCTERNAL THERAPEUTICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| CARGO THERAPEUTICS, INC. | Biotechnology | Chief Operating Officer | |
| ELICIO THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| CARISMA THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer |
Statistiques
Internationale
| Etats-Unis | 41 |
| France | 3 |
| Suisse | 2 |
| Royaume-Uni | 2 |
| Australie | 2 |
Sectorielle
| Health Technology | 29 |
| Consumer Services | 13 |
| Finance | 4 |
| Commercial Services | 4 |
| Technology Services | 2 |
Opérationnelle
| Director/Board Member | 54 |
| Corporate Officer/Principal | 36 |
| Independent Dir/Board Member | 18 |
| Chief Tech/Sci/R&D Officer | 17 |
| Director of Finance/CFO | 14 |
Relations les plus connectées
| Insiders | |
|---|---|
| Jay Venkatesan | 30 |
| Michael Weiser | 26 |
| Timothy Morris | 21 |
| Athena Countouriotis | 17 |
| Sanford J. Hillsberg | 11 |
| Igor Bilinsky | 11 |
| Jim Ziegler | 9 |
| Raymond Stapleton | 9 |
| Corinne Epperly | 8 |
| Debora Barton | 7 |
| Jean-Marc Bellemin | 6 |
| jennifer lee | 5 |
| Igor Gorbatchevsky | 4 |
| Tracy Winton | 4 |
| Friedrich Finckenstein | 3 |
- Bourse
- Insiders
- Michael Swartzburg
- Connexions Sociétés
